$1.58
-0.03 (-1.86%)
Open$1.58
Previous Close$1.61
Day High$1.60
Day Low$1.55
52W High$4.50
52W Low$0.72
Volume—
Avg Volume521.8K
Market Cap6.71M
P/E Ratio—
EPS$-1.82
SectorBiotechnology
Analyst Ratings
Strong Sell
6 analysts
Price Target
+2,496.8% upside
Current
$1.58
$1.58
Target
$41.03
$41.03
$36.60
$41.03 avg
$68.97
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 10.0K | 83.8K | 1.35M |
| Net Income | -8,259,936 | -62,156,709 | -84,207 |
| Profit Margin | -83,520.0% | -79,344.0% | -6.2% |
| EBITDA | -8,343,179 | -66,271,070 | -111,401 |
| Free Cash Flow | — | — | -113,905 |
| Rev Growth | -88.0% | -88.0% | +20.4% |
| Debt/Equity | — | — | 1.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |